{'_data': [['Unknown',
            [['GI',
              u'constipation, diarrhoea), increased salivary secretion. Rare Dry mouth, increased appetite. Hepatobiliary disorders Rare Jaundice, changes of hepatic parameters (elevation of ALT, AST, alkaline phosphatase). Skin and subcutaneous tissue Uncommon Allergic skin reactions (itching, erythema, disorders rash). Musculoskeletal and Uncommon Myasthenia. connective tissue disorders Renal and urinary disorders Rare Urinary retention, incontinence. Reproductive system and Rare Gynaecomastia, impotence, increased or breast disorders reduced libido. General disorders and Common Fatigue, withdrawal symptoms (anxiety, panic, administration site conditions palpitations, sweating, tremor, gastrointestinal disorders, irritability, aggression, disrupted sensory perception, muscle spasms, general malaise, loss of appetite, paranoid psychosis, delirium and epileptic attacks). 4 Investigations Very rare Elevation of transaminases. Known to occur when using benzodiazepines or benzodiazepine-like agents. These reactions may be quite severe. They are more likely to occur in children and the elderly. Diazepam should be discontinued if such symptoms occur (see section 4.4). Pre-existing depression may be unmasked during benzodiazepine use. May occur using therapeutic dosages, the risk increasing at higher dosages. Amnestic effects may be associated with inappropriate behaviour (see section 4.4). The likelihood and degree of severity of withdrawal symptoms is dependent on the duration of treatment, dose level and degree of dependency.']]]],
 '_pages': [10, 11],
 u'_rank': 1,
 u'_type': u'LSFU'}